Dr Mo Yin
Infectious Diseases Physician
Bacterial Resistance Analysis Group
Dr Mo Yin is a highly motivated Infectious Diseases physician driven by the ideal of using quality clinical research to influence patient care and propel health policies. She has been active in epidemiological and clinical research, medical education, as well as hospital administration. She has received numerous awards for her achievements in clinical care, research and teaching.
Currently she is pursuing a PhD, where she is leading a multi-centre randomised control trial to assess the impact of shortening treatment duration for ventilator-associated pneumoniae.
Dr Mo Yin’s career goal is to serve her community focusing on translational research to influence regional and global policies.
Effect of Delays in Concordant Antibiotic Treatment on Mortality in Patients with Hospital-Acquired Acinetobacter spp. Bacteremia: Emulating a Target Randomised Trial with a 13-year Retrospective Cohort.
Lim C. et al, (2021), American journal of epidemiology
Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial.
Mo Y. et al, (2021), BMJ open, 11
Household transmission of carbapenemase-producing Enterobacteriaceae: a prospective cohort study.
Marimuthu K. et al, (2021), The Journal of antimicrobial chemotherapy
Considerations in the use of slit lamp shields to reduce the risk of respiratory virus transmission in coronavirus disease 2019.
Ong SC. et al, (2020), Current opinion in ophthalmology, 31, 374 - 379
Duration of Carbapenemase-Producing Enterobacteriaceae Carriage in Hospital Patients.
Mo Y. et al, (2020), Emerging infectious diseases, 26, 2182 - 2185